论文部分内容阅读
自瑞典学者Berggard于1968年从Wilson氏病与镉中毒患者尿中发现并提取β_2微球蛋白(以下简称β_(2-)M)以来,许多学者已对其结构及代谢进行了研究,并应用于临床.近年,国内对不同病理状态下血、尿β_(2-)M的变化及临床意义报道较多,但正常人的性別、年龄及日常活动等生理性因
Since the Swedish scholar Berggard discovered and extracted β 2 microglobulin in urine of patients with Wilson’s disease and cadmium poisoning (hereinafter referred to as β_ (2-) M) in 1968, many scholars have studied its structure and metabolism and applied In recent years, the changes of blood and urine β_ (2-) M in different pathological conditions in China have been reported in many countries, but the physiological causes such as gender, age and daily activities of normal people